Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.142
Buy
RSI(14)
49.102
Neutral
STOCH(KDJ)(9,3,3)
36.991
Sell
ATR(14)
0.837
Low Volatility
CCI(14)
-53.571
Neutral
Williams %R
61.573
Sell
TRIX(12,20)
0.083
Sell
StochRSI(14)
0.000
Oversold
Search
Sanofi SA
SNYAdd to Watchlist
43.380USD
-0.410-0.94%
Close 07-23 16:00（ET）Quotes delayed by 15 min
104.13BMarket Cap
12.06P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-0.94%
5 Days
-1.88%
1 Month
+4.28%
6 Months
-8.09%
Year to Date
-10.48%
1 Year
-13.52%
Key Figures
43.030Open
43.505High
1.91MVolume
12.06P/E TTM
8.47P/E Dynamic
5.120Dividend TTM
0.08%Turnover Ratio
43.790Prev. Close
42.900Low
56.47MTurnover
17.32P/E Static
1.24P/B
11.80%Div Yield TTM
3.90%ROA
52.68052wk High
0.51Volume Ratio
6.01BNet Profit
2.40BShares
3.5959EPS TTM
0.32Beta
6.87%ROE
42.32552wk Low
1.38%Amplitude
67.33%Gross Margin
104.13BMarket Cap
6.04Reward/Risk
0.98%Risk Rate
TradingKey Stock Score of Sanofi SA
Currency: USD Updated: 2026-07-23Key Insights
Sanofi SA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 53 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 56.27.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Sanofi SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Sanofi SA Highlights
StrengthsRisks
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.07% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 52.67B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 171.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 171.67%.
Undervalued
The company’s latest PE is 12.06, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 225.52M shares, decreasing 13.87% quarter-over-quarter.
Held by Sarah Ketterer
Star Investor Sarah Ketterer holds 9.63M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.46.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
56.274
Target Price
+28.63%
Upside Space
Sanofi SA News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
10
analysts
Buy
Current Rating
56.274
Target Price
+28.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Sanofi SA
SNY
10
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
43.908
Sell
MA10
43.811
Sell
MA20
43.300
Buy
MA50
43.397
Sell
MA100
44.609
Sell
MA200
46.657
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Sanofi SA Info
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Ticker SymbolSNY
CompanySanofi SA
CEOHudson (Paul)
Websitehttps://www.sanofi.com/
Shareholders
Related Instruments
+1.95%
+1.46%
-0.85%
+1.43%
+2.37%
+2.01%
+1.49%
+0.38%
0.00%
+0.71%
+1.27%
+0.15%
-0.03%
+1.31%
0.00%
+0.11%
+8.61%
-0.21%
+2.45%Popular Instruments
FAQs
What is the current price of Sanofi SA (SNY)?
The current price of Sanofi SA (SNY) is 43.38.
What is the symbol of Sanofi SA?
The ticker symbol of Sanofi SA is SNY.
What is the 52-week high of Sanofi SA?
The 52-week high of Sanofi SA is 52.68.
What is the 52-week low of Sanofi SA?
The 52-week low of Sanofi SA is 42.33.
What is the market capitalization of Sanofi SA?
The market capitalization of Sanofi SA is 104.13B.
Is Sanofi SA (SNY) currently rated as Buy, Hold, or Sell?
According to analysts, Sanofi SA (SNY) has an overall rating of Buy, with a price target of 56.27.
What is the Earnings Per Share (EPS TTM) of Sanofi SA (SNY)?
The Earnings Per Share (EPS TTM) of Sanofi SA (SNY) is 3.61.